Corticothalamic circuit and executive dysfunction in Alzheimer's disease and related tauopathies. [PDF]
Ferreira Dos Santos L +2 more
europepmc +1 more source
The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders. [PDF]
Li Z +6 more
europepmc +1 more source
Tau beyond the Brain: Endoplasmic Reticulum Stress and Tau Phosphorylation as Emerging Drivers of Diabetic Nephropathy. [PDF]
Kim NY, Oh CM.
europepmc +1 more source
Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy? [PDF]
Buck SA, Madhavan SS, Sanders LH.
europepmc +1 more source
Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases. [PDF]
Wang H +8 more
europepmc +1 more source
RNA-based therapeutics for Alzheimer's disease and related tauopathies: challenges and opportunities. [PDF]
Rajbanshi B +4 more
europepmc +1 more source
Characterization of [<sup>18</sup>F]SMBT-1 binding substrates in Alzheimer's disease and related disorders: A postmortem biochemical and immunohistochemical study. [PDF]
Abrahamson EE +9 more
europepmc +1 more source
Olfactory dysfunction as a marker of neurodegenerative disease in older adults. [PDF]
Klíčová K +9 more
europepmc +1 more source
Commentary: LRP1 Is a Master Regulator of Tau Uptake and Spread
Conor Fearon +3 more
doaj +1 more source

